We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort (DC Cohort)

This study is currently recruiting participants.
Verified February 2017 by George Washington University
Sponsor:
ClinicalTrials.gov Identifier:
NCT01206920
First Posted: September 22, 2010
Last Update Posted: February 24, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
George Washington University
September 21, 2010
September 22, 2010
February 24, 2017
January 2011
November 2018   (Final data collection date for primary outcome measure)
Following the health of those with HIV throughout the study [ Time Frame: duration of cohort ]
Not Provided
Complete list of historical versions of study NCT01206920 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort
Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort
The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for outpatients with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) in Washington, DC.
All major community and academic clinics treating HIV-infected persons in the District of Columbia (DC) will initially be included in the development of a city-wide "DC Cohort" of HIV-infected persons in care, with consideration to be given subsequently to the inclusion of large private physician practices. Socio-demographics, risk factors, treatments, diagnoses, labs and procedures documented in outpatient medical record systems will be included in the DC Cohort database. Routine reports will be generated every six months for sites comparing their participants' socio-demographics, clinical status, treatments, and outcomes to all other data in the DC Cohort database, and other comparisons specifically requested by sites. All sites will be provided analytic support in research areas of interest.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Study participants will include men, women and children receiving HIV/AIDS care at major publicly-funded, government and academic medical centers in the District of Columbia.
  • HIV
  • AIDS
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
10000
November 2018
November 2018   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patient is receiving care for HIV at one or more of the twelve participating clinics in the DC Cohort.
  • Patient is either age 18 years or older, or seeks HIV care independently and is able to understand and sign informed consent.
  • Patient is a minor who is consented by a parent or legal guardian.

Exclusion Criteria:

  • Patient is unable or refuses to provide informed consent.
  • Minor children ages 12 through 17 who are unaware of their HIV status
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact: Amanda D Castel, MD, MPH 202-994-8325 acastel@gwu.edu
Contact: Lindsey P Happ, MPH 202-994-3340 lpowers@gwu.edu
United States
 
 
NCT01206920
071029
3U01AI069503-03S2 ( U.S. NIH Grant/Contract )
No
Not Provided
Not Provided
George Washington University
George Washington University
National Institute of Allergy and Infectious Diseases (NIAID)
Principal Investigator: Amanda D Castel, MD, MPH George Washington University
George Washington University
February 2017
To Top